That’s just one of the information gaps that providers are left to deal with as they scramble to meet pharmaceutical demands. When Senator John Thune (R-S.D.) asked the panelists about solutions, Ms. Herold quickly jumped in to talk about California’s e-Pedigree requirement, which will be phased in starting in 2015. Every unit-level sale will have to be recorded electronically. The Prescription Drug User Fee Act (PDUFA) reauthorization bill, passed by the Senate this year, included a national lot-level e-Pedigree requirement. However, the House bill did not, nor did the final bill signed by President Obama.
Why Adrian Went Gray

This includes aggressive audits of purchase histories, pedigree documentation, and supplier licensure. Landers continues prescribing brand name GLP-1s to patients who can afford them, but some were forced to make tough choices. Lindsey Landers, an advanced practice nurse in Kentucky, stopped prescribing compounded GLP-1s from a licensed pharmacy after an August 2025 cease and desist from a drug manufacturer. This page may contain sensitive or adult content that’s not for everyone.
Prices Gone Wild: Grey Market ‘scalpers’ Scoring Windfall In American Drug Market

None of the companies manufactures drugs or treats patients. Simply raising the price on something in short supply is only a violation of Federal Trade Commission law if companies agree to create a shortage and raise the price or if they monopolize a market by buying up a product and creating an artificial shortage. Most gray market vendors aren’t large enough to do anything close. Lambson says he understands the frustration of consumers who can’t afford or don’t have access to either brand-name or compounded versions of GLP-1 medications.
Investigation Of “Drug Speculation” By “Gray Market” Drug Companies
- CagriSema is Novo’s next-generation obesity drug candidate, still in clinical trials so not available to the public.
- When Senator John Thune (R-S.D.) asked the panelists about solutions, Ms. Herold quickly jumped in to talk about California’s e-Pedigree requirement, which will be phased in starting in 2015.
- “For a full workup for endotoxins, heavy metals and mass impurities, you’re looking at about $850,” he says.
- This is the secure way to sell your application in the IPO grey market.
- While official supply chains are tightly controlled to guarantee safety, the crisscrossing nature of the gray market can throw the safety of a drug into serious doubt.
Less than four emergency department visits occur for every 1,000 patients dispensed semaglutide, researchers estimated in April in the Annals of Internal Medicine. But just because a drug is off the list doesn’t mean supply is guaranteed. And even with new discounts offered by pharmaceutical companies, the drugs’ prices keep them out of reach for many patients — especially since insurance won’t always cover them.
Significance Of IPO GMP
Vendors would fake tracking numbers that showed packages held up at customs and then demand hundreds of dollars in fees to release the medication. Given the hostile environment brimming with angry senators, one has to give some credit to Patricia Earl, an industry analyst for the National Coalition of Pharmaceutical Distributors. This trade group represents the secondary drug distributors often accused of constituting the gray market pipeline. Appearing before the damning-report-wielding senators (the equivalent of entering the lion’s den just before dinner time), she explained that all members of her association are licensed by the FDA and the Drug Enforcement Administration. Some products sold online are from unregulated sources may pose serious health risks. Due to medication shortages and insurance barriers, we prescribe GLP-1 medications (such as semaglutide and tirzepatide) from a licensed and regulated 503(a) compounding pharmacy.

Gray Area
Those prepared to hand over a pedigree — or a detailed record of a products’ custody — occasionally hear from O’Neal when there’s no other choice. For a pharmacist, trying to determine a product’s supply source in such a web — let alone its origins or authenticity — can be extremely difficult. A breast cancer patient receives a chemotherapy drip at Cape Fear Valley Medical Center in Fayetteville, N.C. Photo by Chris Hondros/Getty Images. We are at a critical time and supporting science journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen scientific literacy and ensure that important societal decisions are made with science in mind.

What Factors Are Influencing IPO GMP?
Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products. Frier Levitt has extensive experience advising pharmacies, drug wholesalers, and supply chain participants on regulatory and enforcement risks related to product sourcing, DSCSA compliance, and state licensing issues. We regularly assist clients in responding to FDA and Board of Pharmacy inquiries, and we counsel businesses on how to avoid exposure under the Lanham Act and other legal theories being pursued by aggressive brand manufacturers. Some “gray” products could be defunct, leaving critical health needs unresolved, while others could contain contaminants with dangerous long-term effects.

Why I Am Not Getting SME IPO Allotment?
The drug is the key ingredient in the blockbuster diabetes and weight-loss medications Ozempic and Wegovy. Both come in prefilled injector pens, which typically take the guesswork out of dosing. The IPO grey market premium refers to the premium or additional price at which IPO shares are traded unofficially before their official listing on a stock exchange.
Grey Market Drugs: Profiting From Poorly Managed US Health Care
Instead it should be ingested sublingually, meaning you have to place it under your tongue. In addition to concerns about cost, there are worries that drugs sold through gray-market sources may be of questionable quality, may not be handled properly or may come from improper sources, or may even be counterfeit or stolen, the Premier report said. Last year she bought a compounding pharmacy’s version of tirzepatide, paying about US$470 monthly, and had lost more than 20 pounds when the FDA announced the ban on compounded weight-loss drugs. Despite the blunder, Spencer didn’t consider returning to compounded versions of the drugs or abandoning them altogether. She is not regularly monitored by a healthcare provider, but says her treatment has led to a “life-changing” reduction in weight, joint pain and blood pressure. “I have been working with a network of hospital, pharmacy, and government representatives to investigate the extent to which ‘gray market’ middleman companies are making substantial profits by engaging in a form of drug speculation,” Cummings wrote.
If the investor gets an allotment and sold the application for around ₹10000 and the profit goes high on listing day around ₹15000 then one should pay ₹5000 to the investor who bought the application. The Kostak rate is the amount that one investor pays to the seller of an IPO application before the IPO listing. As the grey market reacts the Kostak rates also react that way. One can buy and sell their full IPO application on Kostak rates outside the market and fix their profit. The Kostak rates apply whether the investor gets the IPO allotment or not, the buyer should pay the Kostak rates for the IPO.
- In 2015, China became the world’s second largest pharmaceutical market.
- Dr Ramen Goel, director at Mumbai’s weight loss-focused Centre of Bariatric Surgery, said more than half of the dozen or so patients he sees daily ask about obesity drugs.
- The IPO Grey Market Premium serves as an indicator of market sentiment and the perceived value of the IPO shares.
- In fact, it they have become things that we use almost on a daily basis.
- This rapid growth was the result of a combination of societal and economic factors – China’s aging population, wealth distribution, the shift in urbanisation demographics – as well as bespoke policies and law reforms.
For Melanie, the first two weeks on tirzepatide were the roughest. “It felt like somebody donkey-kicked my stomach,” she says. “I thought I was going to die.” She stayed inside, laid on the couch and rode it out. By the third week, most of the side effects had disappeared. In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist.
Anytime the word ‘counterfeiting’ is mentioned, most often than not, we conjure up images of either currency notes, high-end luxury fashion products, or vintage goods. Using identical packaging and symbols to sell off fake products masked as original and mint money, sometimes even at the cost of peoples’ lives. Nevertheless, three exceptions to the previous rules and sanctions were introduced in the last amendment to the Drug Administration Law and entered into force in December 2019. First, any entity or individual importing a small volume of drugs that have been legally marketed in other countries may incur a mitigated punishment or even obtain exemption from punishment at the authorities’ discretion. Second, medical institutions importing a small volume of drugs for urgent clinical needs should obtain approval from national drug administration authorities, and such drugs should be used in designated medical institutions for specific medical purposes. Finally, individuals importing a small volume of drugs for personal use from other countries, in accordance with relevant applicable rules, are exempt from sanctions (Article 124).